Form 4 for ZBH Zimmer Biomet
Accepted 2021-12-21 00:00:00 ET · period of report 2021-12-19 · accession 0001062993-21-013313 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-21 | 2021-12-19 | ZBH | Hanson Bryan C | Pres, CEO, Dir | M - OptEx | $0.00 | +58.5K | 86.4K | +210% | $0 |
| DM | 2021-12-21 | 2021-12-19 | ZBH | Hanson Bryan C | Pres, CEO, Dir | F - Tax | $120.94 | -27.1K | 92.2K | -23% | -$3.28M |
| DM | 2021-12-21 | 2021-12-19 | ZBH | Hanson Bryan C | Pres, CEO, Dir | M - OptEx | $0.00 | -58.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-19 | M | A | 32,950 | $0.00 | 107,493 | D | — | — | (F4) On December 19, 2017, the reporting person was granted 49,425 PRSUs, which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 32,950 PRSUs were earned and vested on December 19, 2021. The remaining 16,475 PRSUs were forfeited. |
| 2 | Common | Common Stock | 2021-12-19 | F | D | 11,826 | $120.94 | 74,543 | D | — | — | (F3) Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of PRSUs. |
| 3 | Common | Common Stock | 2021-12-19 | M | A | 25,520 | $0.00 | 86,369 | D | — | — | (F1) On December 19, 2017, the reporting person was granted 38,280 performance restricted stock units ("PRSUs"), which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 25,520 PRSUs were earned and vested on December 19, 2021. The remaining 12,760 PRSUs were forfeited. (F2) Includes 163 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on June 30, 2021. |
| 4 | Common | Common Stock | 2021-12-19 | F | D | 15,270 | $120.94 | 92,223 | D | — | — | (F3) Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of PRSUs. |
| 5 | Derivative | Performance Restricted Stock Units | 2021-12-19 | M | D | 25,520 | $0.00 | 0 | D | — · — to — | 25,520 Common Stock | (F1) On December 19, 2017, the reporting person was granted 38,280 performance restricted stock units ("PRSUs"), which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 25,520 PRSUs were earned and vested on December 19, 2021. The remaining 12,760 PRSUs were forfeited. (F5) Each PRSU represents a contingent right to receive one share of Company common stock. |
| 6 | Derivative | Performance Restricted Stock Units | 2021-12-19 | M | D | 32,950 | $0.00 | 0 | D | — · — to — | 32,950 Common Stock | (F4) On December 19, 2017, the reporting person was granted 49,425 PRSUs, which were to be earned if and to the extent certain stock price performance goals were achieved by December 19, 2021. The Company's compensation committee determined that, based on actual stock price performance, 32,950 PRSUs were earned and vested on December 19, 2021. The remaining 16,475 PRSUs were forfeited. (F5) Each PRSU represents a contingent right to receive one share of Company common stock. |